Huntington National Bank’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Buy |
4,293
+456
| +12% | +$256K | 0.01% | 393 |
|
|
2026
Q1 | $2.16M | Buy |
3,837
+8
| +0.2% | +$5.13K | 0.01% | 380 |
|
|
2025
Q4 | $2.59M | Buy |
3,829
+69
| +2% | +$47K | 0.02% | 315 |
|
|
2025
Q3 | $2.4M | Buy |
3,760
+109
| +3% | +$66.2K | 0.01% | 321 |
|
|
2025
Q2 | $1.96M | Buy |
3,651
+19
| +0.5% | +$9.09K | 0.01% | 341 |
|
|
2025
Q1 | $1.53M | Sell |
3,632
-144
| -4% | -$62.5K | 0.01% | 372 |
|
|
2024
Q4 | $1.56M | Sell |
3,776
-203
| -5% | -$89K | 0.01% | 364 |
|
|
2024
Q3 | $2.01M | Buy |
3,979
+42
| +1% | +$20.4K | 0.01% | 334 |
|
|
2024
Q2 | $1.92M | Sell |
3,937
-134
| -3% | -$67.3K | 0.01% | 330 |
|
|
2024
Q1 | $2.2M | Sell |
4,071
-28
| -0.7% | -$15.3K | 0.02% | 312 |
|
|
2023
Q4 | $2.28M | Buy |
4,099
+48
| +1% | +$22.5K | 0.02% | 299 |
|
|
2023
Q3 | $1.77M | Buy |
4,051
+5
| +0.1% | +$2.49K | 0.02% | 316 |
|
|
2023
Q2 | $2.03M | Buy |
4,046
+402
| +11% | +$193K | 0.02% | 313 |
|
|
2023
Q1 | $1.82M | Buy |
3,644
+64
| +2% | +$30.6K | 0.02% | 319 |
|
|
2022
Q4 | $1.46M | Buy |
3,580
+259
| +8% | +$101K | 0.02% | 337 |
|
|
2022
Q3 | $1.08M | Sell |
3,321
-95
| -3% | -$34.9K | 0.01% | 359 |
|
|
2022
Q2 | $1.2M | Buy |
3,416
+2,506
| +275% | +$1.02M | 0.01% | 357 |
|
|
2022
Q1 | $498K | Sell |
910
-17
| -2% | -$8.94K | ﹤0.01% | 490 |
|
|
2021
Q4 | $610K | Buy |
927
+56
| +6% | +$35.2K | 0.01% | 458 |
|
|
2021
Q3 | $542K | Sell |
871
-46
| -5% | -$30.9K | 0.01% | 460 |
|
|
2021
Q2 | $579K | Buy |
917
+86
| +10% | +$47.5K | 0.01% | 461 |
|
|
2021
Q1 | $407K | Hold |
831
| – | – | ﹤0.01% | 424 |
|
|
2020
Q4 | $415K | Sell |
831
-148
| -15% | -$66.2K | 0.01% | 409 |
|
|
2020
Q3 | $385K | Sell |
979
-358
| -27% | -$132K | 0.01% | 403 |
|
|
2020
Q2 | $441K | Sell |
1,337
-192
| -13% | -$55.6K | 0.01% | 387 |
|
|
2020
Q1 | $370K | Sell |
1,529
-86
| -5% | -$22.4K | 0.01% | 401 |
|
|
2019
Q4 | $422K | Buy |
1,615
+192
| +13% | +$50.6K | 0.01% | 422 |
|
|
2019
Q3 | $387K | Buy |
1,423
+51
| +4% | +$14.2K | 0.01% | 420 |
|
|
2019
Q2 | $378K | Hold |
1,372
| – | – | 0.01% | 425 |
|
|
2019
Q1 | $307K | Hold |
1,372
| – | – | 0.01% | 446 |
|
|
2018
Q4 | $255K | Hold |
1,372
| – | – | ﹤0.01% | 474 |
|
|
2018
Q3 | $343K | Hold |
1,372
| – | – | 0.01% | 469 |
|
|
2018
Q2 | $299K | Sell |
1,372
-105
| -7% | -$21.6K | 0.01% | 479 |
|
|
2018
Q1 | $283K | Buy |
1,477
+105
| +8% | +$19.4K | ﹤0.01% | 502 |
|
|
2017
Q4 | $215K | Sell |
1,372
-118
| -8% | -$18.6K | ﹤0.01% | 554 |
|
|
2017
Q3 | $232K | Hold |
1,490
| – | – | ﹤0.01% | 547 |
|
|
2017
Q2 | $241K | Sell |
1,490
-1,220
| -45% | -$198K | ﹤0.01% | 533 |
|
|
2017
Q1 | $418K | Sell |
2,710
-331
| -11% | -$45.6K | 0.01% | 473 |
|
|
2016
Q4 | $357K | Hold |
3,041
| – | – | 0.01% | 501 |
|
|
2016
Q3 | $343K | Buy |
3,041
+1,851
| +156% | +$195K | 0.01% | 503 |
|
|
2016
Q2 | $111K | Buy |
1,190
+629
| +112% | +$54K | ﹤0.01% | 721 |
|
|
2016
Q1 | $87K | Sell |
561
-693
| -55% | -$49.9K | ﹤0.01% | 958 |
|
|
2015
Q4 | $91K | Buy |
1,254
+91
| +8% | +$6.49K | ﹤0.01% | 841 |
|
|
2015
Q3 | $86K | Sell |
1,163
-174
| -13% | -$12.5K | ﹤0.01% | 899 |
|
|
2015
Q2 | $86K | Buy |
1,337
+215
| +19% | +$14.9K | ﹤0.01% | 969 |
|
|
2015
Q1 | $87K | Hold |
1,122
| – | – | ﹤0.01% | 962 |
|
|
2014
Q4 | $83K | Buy |
+1,122
| New | +$78.7K | ﹤0.01% | 976 |
|
|
2014
Q3 | – | Sell |
-4,148
| Closed | -$277K | – | 1026 |
|
|
2014
Q2 | $277K | Sell |
4,148
-342
| -8% | -$21.7K | 0.01% | 923 |
|
|
2014
Q1 | $273K | Buy |
4,490
+2,622
| +140% | +$156K | 0.01% | 991 |
|
|
2013
Q4 | $99K | Buy |
1,868
+188
| +11% | +$9.89K | ﹤0.01% | 909 |
|
|
2013
Q3 | $84K | Buy |
1,680
+380
| +29% | +$18.3K | ﹤0.01% | 937 |
|
|
2013
Q2 | $58K | Buy |
+1,300
| New | +$56.8K | ﹤0.01% | 1013 |
|
Other funds holding IDXX
Huntington National Bank's IDXX Position: Q2 2026 in Review
Huntington National Bank increased its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, buying an estimated $256K and bringing the position to 4,293 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #393.
Huntington National Bank first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.59M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Huntington National Bank held 4,293 shares of Idexx Laboratories worth $2.26M as of Q2 2026.
- Huntington National Bank bought 456 Idexx Laboratories shares in Q2 2026, an estimated $256K.
- Idexx Laboratories made up 0.01% of Huntington National Bank's portfolio in Q2 2026, its #393 holding.
- Huntington National Bank first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
- Huntington National Bank's Idexx Laboratories position peaked at $2.59M in Q4 2025.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.